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Abstract
Among several inflammatory markers, high sensitive C-reaction protein (hs-CRP) is outstandingly observed in diabetic 
individuals. Serum hs-CRP is the main marker of inflammation whose levels independently predict the risk of cardiovascular 
events, and it has a prognostic value in heart patients. On the other hand, diabetes can lead to diastolic dysfunction of 
the heart. Diastolic dysfunction can cause symptoms of exertional dyspnea, which restricts the patient’s activity. It is 
likely to predict diastolic dysfunction by screening through hs-CRP. The present investigation was a case-control study 
that was carried out on 52 patient diagnosed with diabetes mellitus type II. After the demographic data were recorded, 
and following the collection of data on the patients’ history, physical examination, and para-clinical measures, individuals 
who had factors interfering with level of serum hs-CRP (kidney and liver diseases, inflammatory and infectious diseases, 
peripheral vascular disease, cerebrovascular disease, connective tissue disease, malignant tumor, trauma, consumption 
of statins, aspirin, ACEI, and fibrates) and diastolic dysfunction (ischemic heart disease, cardiomyopathies, pericardial 
disease, arrhythmias and valvular disease) were crossed out of the study. Serum hs-CRP was measured by nephelometry 
method. According to the results of tissue Doppler echocardiography, these patients are divided into two groups: one 
with diastolic dysfunction and the other without diastolic dysfunction. The serum hs-CRP levels of these patients were 
compared with each other. Among the participants, 30.8% were men and 69.2% were women, 36 individuals (69.2%) had 
diastolic dysfunction while 16 (30.8%) did not. There was a high level of correlation between the level of serumhs-CRP 
and diastolic dysfunction (p=0.02, t=2.36). The results of the present study indicated that there is a correlation between 
level of serum hs-CRP and diastolic dysfunction, such that the more the level of hs-CRP, the higher probability of diastolic 
dysfunction existence will be.
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1.  Introduction
Diabetes mellitus is a metabolic disease whose prevalence 
has been increased over that last several decades, such 
that the number of the patients increased from 30 million 
people in 1985 to 177 million in 2000, and it is predicted 
this number will reach over 320 million by 2030. Diabetes 
is one of the major causes of death and is responsible for 
the death of 3 million people all over the world in 20021.
The number of cardiovascular diseases is increasing 
among diabetic patients. American Heart Association 
has considered diabetes as a risk factor for cardiovascular 
diseases and ranked it at the same level as smoking, 
hypertension, and hyperlipidemia. There is little evidence 
indicating that better control of blood sugar leads to a 
decrease in cardiovascular complications in diabetes, 
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and better control of blood sugar has not convincingly 
reduced cardiac mortality. The rate of heart failure is 
high among diabetic patients, which can be attributed to 
different reasons including atherosclerosis, hypertension, 
and heart cell dysfunction due to a chronic increase in 
hyperglycemia1.
Among several inflammatory markers, hs-CRP 
can outstandingly be seen in diabetic patients. Serum 
hs-CRP is the major marker of inflammation which is 
created by the kidney. This protein increases in response 
to inflammation, injury, and infection2,3. Nowadays, the 
results of a set of prospective epidemiological studies 
have indicated that levels of CRP can alone predict the 
risk of cardiovascular events and has a prognostic value 
in cardiac patients4,5. Myocardial fibrosis is the major 
cause of myocardial stiffness which leads to advanced 
heart diastolic dysfunction which has a higher prevalence 
in inflammatory conditions and causes the symptoms of 
exertional dyspnea and restricts the patient’s activity6.
In some studies, it is reported that mortality rate in 
asymptomatic patients who are in diastolic dysfunction 
phase I during 3-5 years is 5 times more than those with 
normal diastolic function7. Therefore, due to the high 
prevalence of diabetes and its serious cardiac complication, 
it is necessary to diagnose diastolic dysfunction as soon 
as possible so that necessary grounds for reducing the 
costs and increasing the quality of the patient’s life can be 
established by examining the influential factors.
2.  Materials and Methods
Fifty-two 20-55-year-old outpatients with diabetes 
mellitus type II who had referred to Ilam’sHeart Clinic in 
2012-13 and had study inclusion criteria were selected. The 
patients were provided with necessary explanations about 
the study and their written consent was obtained. Patients 
who had intervening factors in the level of hs-CRP like 
kidney and liver diseases, inflammatory and infectious 
diseases, peripheral vascular disease, cerebrovascular 
disease, connective tissue disease, malignant tumor, recent 
injuries, and consumption of ACEI, ASA, statins, and 
fibrates were crossed from the study. An increase of over 
10 mg/L in hs-CRP is in favor of the existence of an acute 
inflammation; therefore, patients with a serum hs-CRP 
level of over 10 mg/L were crossed out of the study. Those 
patients who in their para-clinical examinations were 
known to have factors affecting diastolic function (such 
as valvular disease, pericardial disease, cardiomyopathies, 
and ischemic heart disease) were also crossed out of the 
study.
The questionnaire was aimed at collecting data on 
age, gender, BMI, disease control and treatment method, 
disease duration, alcohol consumption, smoking, and 
family and medical background. ECG was run in order 
to examine ischemic and rhythm disorders. Afterwards, 
ischemic heart diseases were checked using exercise test 
and in some patients using R/O scan. Heart function 
was examined and recorded using tissue Doppler 
echocardiography by an echocardiography subspecialist. 
Patients who had diastolic dysfunction were classified 
into mild, moderate, and acute groups8 (Table 1).
Table 1.    Classification of diastolic dysfunction
Parameter Normal Mild Moderate Acute
E/A ratio 1-2 <0.8 0.8-2 ≥2
DT (ms( 150-200 >200 150-200 <140
E’ Velocity 10≤ <8 <8 <5
E/E’ ratio 8≥ <8 9-14 ≥15
IVRT(m/s) 50-100 ≥100 60-100 ≤60
PVS/PVD ≈1 S>D S<D S<<D
PVa(m/s) <0.35 <0.35 ≥0.35 ≥0.35adur- Adur(ms) <20 <20 ≥30 ≥30
In addition to echocardiography (echo), the patients 
were referred to the laboratory in order to measure the 
chemical biomarkers and levels of hs-CRP. The level of 
serum hs-CRP was measured by nephelometry method.
Afterwards, according to the results of the echo, these 
patients were divided into two groups; one with diastolic 
dysfunction and one without it. The level of hs-CRP of 
these patients was compared, and the basic level of serum 
hs-CRP was classified into four groups: below 0.5 mg/L 
(very low-risk group), 0.5-1 mg/L (low-risk group), 1-3 
mg/L (average risk group), and over 3 mg/L (severe risk 
group), and its relationship with different variables was 
investigated.
3.  Statistics
The collected data were analyzed using SPSS. t-test 
and one-way ANOVA were employed to examine the 
relationship between quantitative variables and the 
classified ones. Chi-square test was run to check the 
relationship between the qualitative variables. The 
relationship between hs-CRP and quantitative variables 
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was examined using Pearson’s correlation. To check the 
capacity of hs-CRP in predicting diastolic dysfunction, 
a logistic regression model was used. The obtained 
values were reported as Mean±SD and the odd ratio was 
reported with a confidence distance of 95%. A p-value of 
below 0.05 was considered to be significant.
4.  Results
Among the participants, 30.8% were men and 69.2% were 
women. The mean age of the participants was 43.37±6.49 
years, and only 17.3% of the patients were below 40 years 
old.
The results of examining the risk factors for cardiac 
disease indicated that 23% of the patients had the family 
history of premature heart disease among their first-
degree relatives. It was also concluded that 96.2% of the 
patients were non-smokers, 100% of the participants had 
not consumed alcohol, 25% had exercised on a daily basis, 
and 19.2% had an intervening factor at hs-CRP level 
(hypertension). The patients’ mean BMI was 27.46±3.81; 
the women had a higher BMI (with an average of 
27.55±4.42) compared to the men. Moreover, most of 
the patients had a normal diastolic and systolic blood 
pressure, and the patients’ cardiac output was normal 
(with a mean of 53.17).
According to the results of the tissue Doppler 
echocardiography, out of the participating patients, 36 
people (69.2%) had and 16 (30.8%) did not have diastolic 
dysfunction. In the present study, first, individuals with 
intervening factors at the level of hs-CRP (including 
hypertension) were compared in terms of the mean hs-
CRP. The results of the independent t-test indicated 
that there was no significant difference between the two 
groups regarding the mean hs-CRP (p=0.471).
According to the drawn tables, the mean hs-CRP 
in the group with diastolic dysfunction was 1.46±0.78 
while it was 0.86±1.01 in the group without diastolic 
dysfunction. The results of the independent t-test showed 
that there was a statistically significant difference between 
the two groups in terms of mean hs-CRP (p=0.02, t=2.36). 
The mean level of hs-CRP increases with the progress of 
the phase of diastolic dysfunction and this relationship is 
statistically significant (p=0.021).
Pearson correlation coefficient indicated that there 
was a positive significant relationship between the level 
of serum hs-CRP and disease duration (p=0.03, r=0.4). 
Pearson correlation coefficient also showed that the level 
of hs-CRP rose with an increase in systolic blood pressure 
in diabetic patients. This coefficient also indicated that 
there was no significant relationship between hs-CRP 
and the variables of BMI, weight, age, HR, EF, and DBP 
(p>0.05). The results of the independent t-test showed 
that there was no significant relationship between the 
level of hs-CRP and gender (p=0.139).
The results of the Chi-square test showed that 
there was no significant relationship between diastolic 
dysfunction and gender (p=0.622). The independent t-test 
showed that there was a significant relationship between 
diastolic dysfunction and age (p=0.018). Moreover, the 
results of the independent t-test indicated that there was 
a significant relationship between diastolic dysfunction 
and disease duration (p=0.041). They also proved that 
there was no significant relationship between diastolic 
dysfunction and the variables of SBP, DBP, BMI, and 
weight (p>0.05).
Table 2.    The demographic characteristics of the 
participants and their correlation with hs-CRP
Variable Mean SD Pearson 
Correlation
p-Value
Age  47.37 6.493 0.063 0.656
Disease duration 5.26 3.94 0.406 0.03
Weight 74.23 1.28 -0.073 0.605
SBP 118.23 9.51 0.287 0.039
DBP 74.50 9.64 0.036 0.798
BMI 27.46 3.81 0.046 0.747
Logistic regression model was employed to examine 
the relationship between the increase probability of 
diastolic dysfunction risk and an increase in the level of 
hs-CRP. This model indicated the relationship between 
these two variables as:
e-1/05 = Exp
This model indicates that with every unit increase in 
hs-CRP, there will be an increase of 2.85 times in the 
probability of diastolic dysfunction (Odd ratio ( 1Exp ) = 
2/85). Since an increase in the level of hs-CRP leads to an 
increase in the risk of cardiovascular diseases, the level of 
serum hs-CRP was divided into four groups: the groups 
with the level of serum below 0.5 mg/L was considered as 
the group with very low risk of cardiovascular diseases, 
0.5-1 mg/L as low risk, 1-3 mg/L as average risk, and over 
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3 mg/L as severe risk. Since a very limited number of 
the patients had hs-CRP level of over 3 mg/L, they were 
also considered in the group with levels of 1-3 mg/L. In 
order to examine the relationship between the level of hs-
CRP as an ordinal variable and diastolic dysfunction, an 
ordinal logistic regression model was employed.
This model indicated that by increasing the level of hs-
CRP from one level to another, the probability of diastolic 
dysfunction increases, such that if the level of the patient’s 
hs-CRP is at the level with average risk, the probability of 
diastolic dysfunction will be 20.8 times more than that of 
someone whose serum hs-CRP is normal.
Table 3.    The mean of the variables among the 
participants according to diastolic dysfunction
D.D. Has Does not 
have
p-Val-
ue
Variable
Age (year)
average
   49±6     44±7 0.018
Duration of 
disease(year)
6.04±4.1 3.66±3.14 0.041
Weight (kg) 2.23±75/02 2.98±72.58 0.527
hs-CRP (mg/L) 1.47±0/79 0.86±1/02 0.022
DBP (mmHg)    74±8     75±13 0.751
SBP (mmHg)  121±9   113±8 0.008
EF 0.42±55.42 0.58±55.58 0.83
HR 0.83±70/11 4.05±66.29 0.215
BMI (kg/m2) 27.46±3/59 27.47±4.37 0.995
Table 4.    Evaluating the grouping parameter of hs-CRP 
in the ordinal logistic regression model
hs-CRP Estimation ability S.E Wald df OR
<0/5 14/132 2
0/5-1 -1/56 1/017 2/38 1 1 (4/8)
0/208
=
1-3 -3/035 0/809 14/060 1 1 (20/8)
0/048
=
Pearson correlation coefficient in the present study 
indicated that there was a positive significant relationship 
between systolic blood pressure and hs-CRP in diabetic 
patients (p=0.005, r=0.38). The positive correlation 
showed that the level of the diabetic patients’ hs-CRP level 
increases with an increase in their systolic blood pressure. 
Since there was a significant correlation between hs-CRP 
and systolic blood pressure, a linear regression model of 
the relationship between these two variables was assessed 
as y=-1.96+0.027 SBP.
This model shows that with every unit increase in 
systolic blood pressure in diabetic patients, the level of 
hs-CRP increases by 0.027. In this model, serum hs-CRP 
level can be measured based on blood pressure.
The Pearson correlation in this study indicated that 
there was a positive significant relationship between 
diabetes duration and hs-CRP in diabetic patients 
(p=0.03, r=0.406). In the linear regression model, the 
linear correlation between the two variables was assessed 
as y(hs-CRP) =0.779+0.093 Time.
This model shows that with every passing year from the 
development of diabetes, the level of hs-CRP increases by 
0.093. In this model, hs-CRP can be measured according 
to the disease duration.
5.  Discussion
The results of the present study indicated that there was 
a strong correlation between the level of serum hs-CRP 
and diastolic dysfunction, such that the higher the level 
of hs-CRP, the more probable the existence of diastolic 
dysfunction and its more advanced phases would be 
resulted.
There were a positive correlation and a significant 
relationship between diabetes duration and systolic blood 
pressure in diabetic patients. There was no significant 
relationship between hs-CRP and the variables of BMI, 
weight, age, HR, EF, and DBP. The results of the study 
also showed that there was no statistically significant 
relationship between the level of serum hs-CRP and 
gender. There was a significant relationship between 
diastolic dysfunction and age and disease duration. 
However, there was no significant relationship between 
diastolic dysfunction and the variables of SBP, DBP, BMI, 
gender, and weight.
No similar study has been carried out in Iran, and there 
are very few studies focusing on the relationship between 
biomarkers of serum hs-CRP and diastolic dysfunction.
In their prospective study, Rajaram et al. focused 
on the relationship between hs-CRP and diastolic 
dysfunction among Latin Americans during 2004-2006 in 
Chicago, the USA. Serum hs-CRP was directly related to 
diastolic dysfunction (p=0.04, CI=1.07-10.5 (95%), Odds 
Ratio=3.36). Diastolic dysfunction is prevalent among 
African Americans and is independently related to the 
increased levels of hs-CRP9.
In their study, Michowitz et al. (2006) examined the 
predicting role of hs-CRP in patients with heart diastolic 
heart failure. In that study, the level of hs-CRP was different 
in patients with diastolic and diastolic HF; however, after 
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the symptoms alleviated, the level of hs-CRP was higher 
than that of healthy individuals (p<0.0001). In patients, 
this diastolic HF, the level of hs-CRP was related to NYHA 
classification. The results of that study indicated that the 
level of hs-CRP in the patients with diastolic HF is high 
and is related to the severity of the disease10.
In the study carried out by Amanullah in Benghazi, 
Libya (2010), the level of hs-CRP in diabetic and 
non-diabetic patients was taken into consideration. 
Anthropometric indices were higher in diabetic patients 
than non-diabetic ones. The level of hs-CRP was higher 
among diabetic patients. The levels of serum hs-CRP 
were directly related with anthropometric indices. There 
is a correlation between hs-CRP and sugar control with 
HBA1C. The study indicated that there was a strong 
correlation between hs-CRP and diabetes11. 
In the study carried out by Yorulmaz et al. in Istanbul, 
the predicting role of hs-CRP in the development of 
cardiovascular diseases among diabetic patients was 
taken into account. In a recent study, it was concluded 
that there are atleast one of the non-metabolic factors 
that can enhance hs-CRP, which refers to the limited use 
of hs-CRP as the predictor of the development risk of 
cardiovascular diseases among diabetic patients. There 
are numerous factors that can affect the level of hs-CRP; 
therefore, using hs-CRP has limited value as the factor to 
predict the risk of cardiovascular diseases among diabetic 
patients12.
6.  Conclusion
Previously conducted studies showed that diastolic 
dysfunction is independently associated with increased 
level of hs-CRP. The level of hs-CRP is high in patients 
suffering from HF diastolic and it is directly associated with 
the severity of the disease. According to several studies, 
the level of hs-CRP is higher in diabetic patients that other 
people and the serum level of hs-CPR is directly associated 
with anthropometric indices. Some other studies have 
introduced several factors which have the potential of 
affecting the level of hs-CPR; thus, applying hs-CPR as a 
predictor of the risk of cardiovascular disease in diabetic 
patients is of limited value. The present study showed that 
there is a considerable correspondence between the serum 
level of hs-CPR and diastolic dysfunction; i.e. the higher 
the level of hs-CPR, the higher the risk of dysfunction 
diastolic. There is, also, a significant relationship between 
the serum level of hs-CPR and duration of diabetes and 
systolic blood pressure. This study showed a significant 
relationship between diastolic dysfunction with age and 
duration of diabetes. 
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